These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 27748842)
1. Downregulation of ZEB2-AS1 decreased tumor growth and metastasis in hepatocellular carcinoma. Lan T; Chang L; Wu L; Yuan Y Mol Med Rep; 2016 Nov; 14(5):4606-4612. PubMed ID: 27748842 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
3. Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin. Chang L; Li C; Lan T; Wu L; Yuan Y; Liu Q; Liu Z Mol Med Rep; 2016 Feb; 13(2):1541-50. PubMed ID: 26707238 [TBL] [Abstract][Full Text] [Related]
4. Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma. Zhang L; He T; Yan Y; Zhang Y; Zhou X; Huang P; Kong Y; Xie M; Zhang L; Sun Q; Zhou D; Xie H; Zhou L; Zheng S; Wang W Biomed Res Int; 2016; 2016():3608914. PubMed ID: 27896271 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA. Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
7. LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma. Zhou Y; Huan L; Wu Y; Bao C; Chen B; Wang L; Huang S; Liang L; He X Cancer Lett; 2020 Jan; 469():399-409. PubMed ID: 31730902 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition. Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma. Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma. Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837 [TBL] [Abstract][Full Text] [Related]
13. ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentin. Qin Y; Yu J; Zhang M; Qin F; Lan X Mol Med Rep; 2019 Mar; 19(3):2297-2306. PubMed ID: 30664206 [TBL] [Abstract][Full Text] [Related]
14. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
15. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis. Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801 [TBL] [Abstract][Full Text] [Related]
16. Effects of UPF1 expression on EMT process by targeting E‑cadherin, N‑cadherin, Vimentin and Twist in a hepatocellular carcinoma cell line. Li Y; Zhang T; Qin S; Wang R; Li Y; Zhou Z; Chen Y; Wu Q; Su F Mol Med Rep; 2019 Mar; 19(3):2137-2143. PubMed ID: 30628676 [TBL] [Abstract][Full Text] [Related]
17. Malic enzyme 1 induces epithelial-mesenchymal transition and indicates poor prognosis in hepatocellular carcinoma. Wen D; Liu D; Tang J; Dong L; Liu Y; Tao Z; Wan J; Gao D; Wang L; Sun H; Fan J; Wu W Tumour Biol; 2015 Aug; 36(8):6211-21. PubMed ID: 25753478 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma. Qiu L; Tang Q; Li G; Chen K Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma. Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]